New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
07:47 EDTDSCODiscovery Labs receives new U.S. patent for pulmonary surfactant formulations
Discovery Laboratories announced it has received a patent issued by the United States Patent and Trademark Office entitled "Pulmonary Surfactant Formulations." The claims of the patent provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028.
News For DSCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 15, 2014
07:36 EDTDSCODiscovery Labs to collaborate with Battelle For Aerosurf program
Discovery Laboratories has entered into a strategic collaboration with Battelle, an independent research and development organization with 35 years of specific expertise in aerosol science. The parties intend to further develop Discovery Labs' proprietary capillary aerosol generator - or CAG - for use in the planned Aerosurf phase 3 clinical program and, if approved, initial commercialization. The CAG is currently being used in neonatal intensive care units for the company's Aerosurf phase 2 clinical program for the treatment of respiratory distress syndrome in premature infants. Battelle and Discovery Labs generally will share equally in the agreed costs of the device development for the Aerosurf RDS program. In consideration for its investment and expertise, Battelle will receive warrants and future royalties on AEROSURF sales and license sales revenues.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use